Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00941252 | ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial(ITIC) | completed | Phase 2 / Phase 3 | 60 | Medical University of ViennaOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| NCT01258413 | Laparoscopic vs Abdominal Radical Hysterectomy In Patients With Early Cervical Cancer | completed | Phase 3 | 30 | Hospital Nossa Senhora da ConceicaoOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01262144 | SUV Max as Predictor of Outcome in Cervical Cancer | completed | — | 50 | Rambam Health Care CampusOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT00579787 | Prospective Study Assessing Emotional, Sexual and Quality of Life Concerns Of Women Undergoing Removal of the Cervix Versus Removal of the Uterus,Ovaries and Fallopian Tubes For Treatment Of Early Stage Cervical Cancer | completed | — | 72 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 2, 2010 | clinicaltrials |
| NCT00369018 | A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions. | completed | Phase 1 / Phase 2 | 96 | PhotocureINDUSTRY | 2 | Nov 30, 2010 | clinicaltrials |
| NCT00741533 | Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital | completed | — | 172 | Chulalongkorn UniversityOTHER | 1 | Nov 18, 2010 | clinicaltrials |
| NCT00989443 | Safety and Tolerability of Cidofovir Gel Applied on Cervix Squamous Lesions | completed | Phase 1 | 6 | Mithra PharmaceuticalsINDUSTRY | 1 | Oct 21, 2010 | clinicaltrials |
| NCT00340184 | A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients | completed | Phase 2 | 55 | Korean Gynecologic Oncology GroupOTHER | 1 | Oct 19, 2010 | clinicaltrials |
| NCT00285207 | Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix | completed | Phase 2 | 147 | Tigris PharmaceuticalsINDUSTRY | 1 | Oct 11, 2010 | clinicaltrials |
| NCT00735150 | Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk | completed | — | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 11, 2010 | clinicaltrials |
| NCT00097409 | Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 1 | Oct 4, 2010 | clinicaltrials |
| NCT00002508 | Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors | completed | Phase 1 / Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00531570 | Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma | completed | — | 100 | NYU Langone HealthOTHER | 1 | Sep 23, 2010 | clinicaltrials |
| NCT00003598 | UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia(IRB 1996-0189) | completed | N/A | 180 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 22, 2010 | clinicaltrials |
| NCT00082654 | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients | completed | N/A | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217529 | Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217555 | Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217568 | Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00002977 | Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission | completed | Phase 1 | 45 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00003080 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | completed | Phase 1 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00900679 | Effects of a Teaching Intervention With an Advanced Practice Nurse on Quality of Life and Psychosocial and Symptom Distress in Patients With Ovarian Cancer | completed | N/A | 110 | City of Hope Medical CenterOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00648102 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer(CDX1307-02) | completed | Phase 1 | 36 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00709462 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | completed | Phase 1 | 48 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00979342 | Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System | completed | N/A | 40 | Hologic, Inc.INDUSTRY | 1 | Jul 23, 2010 | clinicaltrials |
| NCT00189410 | Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours | completed | Phase 2 | 140 | AGO Study GroupOTHER | 1 | Jul 20, 2010 | clinicaltrials |
| NCT01160185 | Meta-analysis of Efficacy of Topotecan | completed | — | 1 | GlaxoSmithKlineINDUSTRY | 0 | Jul 12, 2010 | clinicaltrials |
| NCT00776074 | A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. | completed | Phase 2 | 80 | TakedaINDUSTRY | 0 | Jun 22, 2010 | clinicaltrials |
| NCT00109993 | Campath-1H + FK506 and Methylprednisolone for GVHD | completed | Phase 2 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT01124435 | Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients(carbo-cox2) | completed | Phase 2 | 45 | Catholic University of the Sacred HeartOTHER | 1 | Jun 4, 2010 | clinicaltrials |
| NCT00410657 | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant | completed | Phase 2 | 53 | Fred Hutchinson Cancer CenterOTHER | 1 | May 14, 2010 | clinicaltrials |
| NCT00101257 | Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer | completed | Phase 1 | 18 | Fred Hutchinson Cancer CenterOTHER | 1 | May 7, 2010 | clinicaltrials |
| NCT00063401 | Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer | completed | Phase 2 | 39 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 8, 2010 | clinicaltrials |
| NCT00004157 | Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00005941 | Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00010283 | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00098800 | Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries | completed | N/A | 40 | University of ArizonaOTHER | 1 | Mar 24, 2010 | clinicaltrials |
| NCT00261027 | Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer | completed | Phase 2 | 30 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00160472 | Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms | completed | N/A | 110 | United States Department of DefenseFED | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00291837 | CT-2106 for the Second Line Treatment of Ovarian Cancer | completed | Phase 2 | 40 | CTI BioPharmaINDUSTRY | 3 | Feb 26, 2010 | clinicaltrials |
| NCT00239980 | Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) | completed | Phase 2 | 77 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00944944 | Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema | completed | — | 58 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 1, 2010 | clinicaltrials |
| NCT00632190 | Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy | completed | N/A | 1,800 | British Columbia Cancer AgencyOTHER | 0 | Jan 28, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00733109 | Management of Cervical Intraepithelial Neoplasia Grade 2(CIN2) | completed | Phase 4 | 90 | Universidade Cidade de Sao PauloOTHER | 1 | Jan 11, 2010 | clinicaltrials |
| NCT00164658 | Evaluating Tools for Health Promotion and Disease Prevention | completed | Phase 1 | 8,400 | Centers for Disease Control and PreventionFED | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00249990 | Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) | completed | Phase 2 | 39 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Jan 24, 2011source: clinicaltrials